MAPT and Alzheimer disease: As these studies were focused on the comparison between the behavioral effects of muscarinic antagonism and dopaminergic stimulation in tau models of AD, rather than on a comparison of the impact of muscarinic antagonism in tau mice with non-tau mice, wildtype mice were not employed.